Cinfa Group inaugurates new state-of-the-art facilities to double its production of medicines
The facility, known as Nave Neo and developed with 4.0 technology, has involved a total investment of approximately 40 million euros. Thanks to this new
The facility, known as Nave Neo and developed with 4.0 technology, has involved a total investment of approximately 40 million euros. Thanks to this new
The event, organised by Navarra Health Cluster (NHC) and ADItech, brought together representatives from 11 entities of the Navarra R&D&I System (SINAI), as well as
The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These
The NAGENdata project is a personalised medicine initiative, financed by the Government of Navarra, with the aim of promoting the health of citizens as well
3P Biopharmaceuticals and Biovan, two leading biotechnology and Contract Development and Manufacturing (CDMO) organisations, are behind this initiative. They aim to further expand their value
The call, called EP-PerMed, will run for the next 7 years. In each of these years, proposals may be submitted for funding of up to
The sector, which has more than 80 companies and employs 31,000 people in the Autonomous Community of Navarre, has increased its turnover by 23% since
The medicines distributor, which currently serves 525 of the 600 pharmacies in Navarre, has doubled its turnover in recent years. It has gone from a
The Navarra Health Cluster opens this September 1st the call for applications for the 1st Euroregional Bio-Health Award. The aim of this award is to promote
The Belgian multinational pharmaceutical company employs around 100 employees in the Comunidad Foral, 61 % of whom are women. The plant has also specialised in